Introduction The most common biomarker for HCC is serum alpha-fetoprotein (AFP). AFP is
used for screening and diagnosing HCC, and also, it is used for predicting prognosis and …

The Milan criteria (MC) remain the cornerstone for the selection of patients with
hepatocellular cancer (HCC) to be listed for liver transplantation (LT). Recently, several …

Objective Albumin-to-alkaline phosphatase ratio (AAPR), a newly developed blood
biomarker, has been reported to have prognostic value in several types of cancer. This study …

Liver transplantation (LT) for hepatocellular carcinoma is still a hot topic, and the main factor
that is associated with the success of treatment is to determine the patients who will benefit …

Purpose To evaluate the effect of hepatitis D virus (HDV) on hepatitis B virus-hepatocellular
carcinoma (HBV-HCC) co-recurrence in patients undergoing living donor liver …

Context Astragalus polysaccharide (APS) is a new tumour therapeutic drug, that has an
inhibitory effect on a variety of solid tumours. Tumour cell immunosuppression is related to …

Background: A characteristic of Hepatocellular Carcinoma (HCC) is to invade the portal
venous system in the liver as a means of spread within the liver and systemically. The …

Research on liver transplantation (LT) for liver cancer has gained increasing attention. This
paper has comprehensively described the current status, hotspots and trends in this field. A …

Background Hepatocellular carcinoma (HCC) is one of the most common malignancies
worldwide. The survival rate after hepatectomy as the first line of treatment for HCC depends …

BACKGROUND There is increasing interest in transplanting patients with hepatocellular
carcinoma (HCC) with tumors greater than 5 cm (Milan criteria). AIM To investigate possible …